Skip to content

Safety and Efficacy Study in Recurrent Grade IV Glioma

Locations:

University of Southern California
Los Angeles, California, United States, 90033

Cleveland Clinic
Cleveland, Ohio, United States, 44333

University of Washington Seattle Cancer Care Alliance
Seattle, Washington, United States, 98109

Contacts:

Laurie Mellott    949-428-6650    laurie.mellott@clindatrix.com

Audrey DeRamos    949-428-6660  audrey.deramos@clindatrix.com

Inclusion criteria: 

For those experiencing Recurrence or Progression

Treatment Protocol: 

Patients will take Perillyl Alcohol via a nebulizer four times a day

Link: 

https://clinicaltrials.gov/ct2/show/NCT02704858

Share on facebook
Share on email
Share on twitter
Share on linkedin

More Perillyl Alcohol Trials

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

More Perillyl Alcohol Trials